InsiderTrades.com logo
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

TCRX Insider Trading

Insider Ownership Percentage: 2.76%
Insider Buying (Last 12 Months): $248,928.70
Insider Selling (Last 12 Months): $951,885.08

TScan Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at TScan Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TScan Therapeutics Share Price & Price History

Current Price: $4.41
Price Change: ▼ Price Decrease of -0.41 (-8.51%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for TCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

TScan Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2024Barbara KlenckeDirectorBuy5,000$5.29$26,450.0045,000View SEC Filing Icon  
8/26/2024Barbara KlenckeDirectorBuy5,000$5.53$27,650.0040,000View SEC Filing Icon  
8/23/2024Barbara KlenckeDirectorBuy5,000$5.69$28,450.0035,000View SEC Filing Icon  
8/23/2024Zoran ZdraveskiInsiderSell164,686$5.78$951,885.084,716View SEC Filing Icon  
12/18/2023Timothy J BarberichDirectorBuy28,830$4.89$140,978.7066,710View SEC Filing Icon  
12/14/2023Barbara KlenckeDirectorBuy5,000$5.08$25,400.0030,000View SEC Filing Icon  
6/2/2023Timothy J BarberichDirectorBuy37,880$2.63$99,624.4037,880View SEC Filing Icon  
5/31/2023Lynx1 Capital Management LpMajor ShareholderSell25,400$2.52$64,008.005,224,600View SEC Filing Icon  
12/27/2022Brian M. SilverCFOBuy2,842$1.50$4,263.0029,727View SEC Filing Icon  
5/18/2022David P SouthwellCEOBuy25,000$3.59$89,750.00171,569View SEC Filing Icon  
3/24/2022Brian M. SilverCFOBuy15,000$3.40$51,000.00View SEC Filing Icon  
See Full Table
This company will win the AI race
From Porter & Company   |   Ad
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for TScan Therapeutics (NASDAQ:TCRX)

82.83% of TScan Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TScan Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC973,466$4.85M0.0%+8.1%1.838%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC58,067$0.29M0.0%+341.1%0.110%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd22,438$0.11M0.0%N/A0.042%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC93,876$0.47M0.0%-5.2%0.177%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP126,345$0.63M0.0%+38.9%0.239%Search for SEC Filing on Google Icon
11/15/2024State Street Corp756,499$3.77M0.0%+24.4%1.428%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp99,133$0.49M0.0%+3.9%0.187%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.103,440$0.52M0.0%N/A0.195%Search for SEC Filing on Google Icon
11/15/2024Checkpoint Capital L.P.825,341$4.11M2.0%N/A1.558%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC84,699$0.42M0.0%-21.3%0.160%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC23,363$0.12M0.0%+129.1%0.044%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC1,016,375$5.06M1.5%+8.0%1.919%Search for SEC Filing on Google Icon
11/13/2024Brown Brothers Harriman & Co.143,051$0.71M0.0%+88.2%0.270%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP71,800$0.36M0.0%-89.2%0.136%Search for SEC Filing on Google Icon
11/6/2024Cornercap Investment Counsel Inc.10,788$54K0.0%-53.0%0.020%Search for SEC Filing on Google Icon
10/25/2024abrdn plc371,655$1.85M0.0%+27.2%0.702%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC15,563$78K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company15,383$90K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/15/2024Troluce Capital Advisors LLC92,832$0.54M0.1%N/A0.176%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC940,831$5.50M1.1%N/A1.780%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP307,487$1.80M0.0%+60.8%0.582%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can120,454$0.75M0.0%N/A0.228%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC13,600$80K0.0%-73.3%0.026%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC80,000$0.47M0.0%+70.2%0.151%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP11,882$70K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/9/2024Brown Brothers Harriman & Co.76,024$0.45M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/8/2024Cornercap Investment Counsel Inc.22,940$0.13M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.47,481$0.28M0.0%+48.9%0.090%Search for SEC Filing on Google Icon
8/2/2024Privium Fund Management UK Ltd12,103$69K0.0%-23.5%0.023%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers46,867$0.27M0.0%N/A0.089%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp116,658$0.68M0.0%N/A0.221%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,808,152$14.36M0.0%+1.1%3.776%Search for SEC Filing on Google Icon
5/10/2024Tocqueville Asset Management L.P.212,200$1.69M0.0%N/A0.443%Search for SEC Filing on Google Icon
4/17/2024Cannon Global Investment Management LLC17,500$0.14M0.4%N/A0.037%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE21,573$0.13M0.0%+30.2%0.045%Search for SEC Filing on Google Icon
2/12/2024Letko Brosseau & Associates Inc.20,700$0.12M0.0%-36.1%0.043%Search for SEC Filing on Google Icon
1/31/2024abrdn plc200,000$1.17M0.0%N/A0.418%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE16,575$42K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/9/2023Letko Brosseau & Associates Inc.32,400$83K0.0%N/A0.068%Search for SEC Filing on Google Icon
8/15/2023BVF Inc. IL2,989,474$7.47M0.2%N/A12.338%Search for SEC Filing on Google Icon
8/10/2023Monashee Investment Management LLC400,000$1M0.2%N/A1.651%Search for SEC Filing on Google Icon
7/26/2023Privium Fund Management B.V.15,825$40K0.0%N/A0.065%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.546,916$1.15M0.2%N/A2.257%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC514,655$0.80M0.1%-7.8%2.137%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.1,077,080$3.29M0.2%N/A4.482%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC557,915$1.70M0.2%-25.4%2.322%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.11,000$34K0.0%N/A0.046%Search for SEC Filing on Google Icon
11/1/2022Privium Fund Management UK Ltd15,825$48K0.1%N/A0.066%Search for SEC Filing on Google Icon
5/17/2022RA Capital Management L.P.1,021,764$2.86M0.1%-18.6%4.299%Search for SEC Filing on Google Icon
5/17/2022Hhlr Advisors LTD.669,513$1.88M0.0%-47.8%2.817%Search for SEC Filing on Google Icon
4/26/2022Marquette Asset Management LLC28,895$81K0.0%+33.7%0.122%Search for SEC Filing on Google Icon
2/15/2022Deer Management Co. LLC1,245,505$5.61M0.1%N/A5.240%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.550,000$2.48M0.0%+10.8%2.314%Search for SEC Filing on Google Icon
1/19/2022Marquette Asset Management LLC21,618$97K0.0%N/A0.091%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC22,200$0.19M0.0%N/A0.093%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP139,566$1.16M0.0%N/A0.582%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$0.63M0.0%N/A0.313%Search for SEC Filing on Google Icon
11/12/2021DC Investments Management LLC35,563$0.30M0.6%N/A0.148%Search for SEC Filing on Google Icon
11/12/2021DC Funds LP630,000$5.25M20.6%N/A2.629%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,500,577$12.52M0.0%N/A6.261%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC100,000$0.83M0.2%N/A0.417%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TScan Therapeutics logo
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Read More on TScan Therapeutics

Today's Range

Now: $4.41
Low: $4.31
High: $4.85

50 Day Range

MA: $5.31
Low: $4.41
High: $5.94

52 Week Range

Now: $4.41
Low: $3.73
High: $9.69

Volume

244,150 shs

Average Volume

253,751 shs

Market Capitalization

$233.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of TScan Therapeutics?

TScan Therapeutics' top insider shareholders include:
  1. Lynx1 Capital Management Lp (Major Shareholder)
  2. Timothy J Barberich (Director)
  3. Barbara Klencke (Director)
  4. Brian M Silver (CFO)
  5. Zoran Zdraveski (Insider)
Learn More about top insider investors at TScan Therapeutics.

Who are the major institutional investors of TScan Therapeutics?

TScan Therapeutics' top institutional investors include:
  1. Great Point Partners LLC — 1.92%
  2. Geode Capital Management LLC — 1.84%
  3. Checkpoint Capital L.P. — 1.56%
  4. State Street Corp — 1.43%
  5. abrdn plc — 0.70%
  6. Brown Brothers Harriman & Co. — 0.27%
Learn More about top institutional investors of TScan Therapeutics stock.

Which major investors are selling TScan Therapeutics stock?

In the previous quarter, TCRX stock was sold by these institutional investors:
  1. LMR Partners LLP
  2. Walleye Capital LLC
  3. Cornercap Investment Counsel Inc.
  4. Jane Street Group LLC

Which major investors are buying TScan Therapeutics stock?

In the last quarter, TCRX stock was acquired by institutional investors including:
  1. Checkpoint Capital L.P.
  2. State Street Corp
  3. Jacobs Levy Equity Management Inc.
  4. abrdn plc
  5. Great Point Partners LLC
  6. Geode Capital Management LLC
  7. Brown Brothers Harriman & Co.
  8. Barclays PLC
Within the previous year, these company insiders have bought TScan Therapeutics stock:
  1. Lynx1 Capital Management Lp (Major Shareholder)
  2. Timothy J Barberich (Director)
  3. Barbara Klencke (Director)
Learn More investors buying TScan Therapeutics stock.
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.